Defactinib
About
Therapy type: Targeted therapy
Therapy strategy: FAK inhibition
Mappings
NCI Thesaurus: Defactinib (ncit:C79809)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Type | Biomarker(s) | Cancer type | Therapy(ies) | |
---|---|---|---|---|
Sensitivity (+) | KRAS p.G12C | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib | |
Sensitivity (+) | KRAS p.G12V | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib |